Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ABVC | ABVC BioPharma, Inc.

Index- P/E- EPS (ttm)-3.84 Insider Own38.99% Shs Outstand3.31M Perf Week-11.76%
Market Cap4.20M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float2.66M Perf Month-47.50%
Income-12.70M PEG- EPS next Q- Inst Own2.00% Short Float / Ratio0.75% / 0.02 Perf Quarter-82.20%
Sales0.80M P/S5.25 EPS this Y-1.20% Inst Trans-91.94% Short Interest0.02M Perf Half Y-83.85%
Book/sh-0.11 P/B- EPS next Y- ROA-125.30% Target Price- Perf Year-86.00%
Cash/sh0.05 P/C21.00 EPS next 5Y- ROE-491.10% 52W Range1.03 - 18.70 Perf YTD-83.20%
Dividend- P/FCF- EPS past 5Y- ROI-320.40% 52W High-94.39% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin46.50% 52W Low1.94% ATR0.22
Employees19 Current Ratio0.40 Sales Q/Q-98.00% Oper. Margin- RSI (14)30.17 Volatility11.30% 11.91%
OptionableNo Debt/Eq- EPS Q/Q-15.20% Profit Margin- Rel Volume0.06 Prev Close1.09
ShortableYes LT Debt/Eq- EarningsMar 31 AMC Payout- Avg Volume811.78K Price1.05
Recom3.00 SMA20-19.35% SMA50-56.37% SMA200-81.67% Volume49,228 Change-3.67%
Aug-23-23 08:30AM
Aug-17-23 09:19AM
Aug-10-23 08:30AM
Aug-07-23 08:30AM
Aug-03-23 09:20AM
08:30AM Loading…
Aug-01-23 08:30AM
Jul-31-23 09:30AM
Jul-27-23 09:22AM
Jul-26-23 08:30AM
Jul-24-23 12:30PM
Jul-06-23 08:30AM
Jun-26-23 08:30AM
Jun-20-23 08:30AM
Jun-12-23 08:30AM
Jun-06-23 08:30AM
08:30AM Loading…
May-22-23 08:30AM
May-04-23 08:30AM
Apr-26-23 08:30AM
Apr-10-23 08:30AM
Apr-06-23 08:30AM
Mar-31-23 06:49PM
Mar-20-23 07:00AM
Mar-14-23 07:00AM
Feb-28-23 08:30AM
Feb-23-23 04:16PM
Feb-21-23 08:30AM
Jan-19-23 08:30AM
Jan-18-23 08:25AM
Jan-05-23 08:30AM
Dec-20-22 11:05AM
08:30AM Loading…
Nov-17-22 08:30AM
Nov-14-22 06:20PM
Nov-07-22 08:30AM
Nov-02-22 08:30AM
Oct-05-22 08:30AM
Sep-23-22 08:30AM
Sep-16-22 09:36AM
Sep-13-22 08:30AM
Sep-09-22 08:30AM
Aug-22-22 08:30AM
Aug-18-22 08:30AM
Aug-15-22 05:48PM
Aug-02-22 08:30AM
Jul-18-22 08:30AM
Jul-13-22 08:30AM
Jul-06-22 08:30AM
Jun-30-22 08:30AM
Jun-21-22 08:30AM
Jun-16-22 08:30AM
Jun-10-22 08:30AM
Jun-07-22 01:10PM
Jun-01-22 08:30AM
May-25-22 08:30AM
May-23-22 07:30AM
May-16-22 05:46PM
May-13-22 08:30AM
May-12-22 09:00AM
May-10-22 08:30AM
May-05-22 08:30AM
May-03-22 08:30AM
Apr-28-22 08:30AM
Apr-26-22 08:30AM
Mar-31-22 04:18PM
Mar-23-22 09:25AM
Mar-08-22 06:15AM
Feb-02-22 08:00AM
Jan-05-22 08:30AM
Dec-22-21 08:30AM
Dec-15-21 08:30AM
Dec-10-21 01:38PM
Dec-09-21 08:30AM
Nov-15-21 04:33PM
Nov-11-21 09:00AM
Nov-03-21 11:18AM
Nov-02-21 06:18AM
Nov-01-21 11:32AM
Oct-27-21 08:30AM
Oct-15-21 12:05PM
Oct-12-21 08:30AM
Sep-13-21 08:30AM
Sep-01-21 03:54PM
Aug-30-21 08:30AM
Aug-26-21 08:30AM
Aug-12-21 08:27AM
Aug-06-21 08:30AM
Aug-03-21 08:30AM
Jun-09-21 10:20AM
Jan-27-21 04:55AM
Jan-06-21 09:00AM
ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1703, which is in Phase II clinical trials for the treatment of metastatic pancreatic cancer; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; ABV-1601 that is in Phase I/II clinical trials for treating depression in cancer patients; ABV-1701 Vitargus that is in Phase II clinical trials for the treatment of retinal detachment or vitreous hemorrhage; and ABV-1519, which is in Phase I/II clinical trials for the treatment of non-small cell lung cancer. ABVC BioPharma, Inc. has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California. ABVC BioPharma, Inc. is a subsidiary of YuanGene Corporation.